Skip to main content
. 2023 Jun 30;14:1177403. doi: 10.3389/fimmu.2023.1177403

Figure 3.

Figure 3

Relapse-free survival (RFS) analysis in all 991 patients with ovarian cancer based on the NLR (A), LMR (B), PLR (C), SII (D), and PNR (E).